108 related articles for article (PubMed ID: 17631549)
21. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Zhao TT; Li JG; Li YM
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
[TBL] [Abstract][Full Text] [Related]
22. Incidental PET/CT findings in the cancer patient: how should they be managed?
Beatty JS; Williams HT; Aldridge BA; Hughes MP; Vasudeva VS; Gucwa AL; David GS; Lind DS; Kruse EJ; McLoughlin JM
Surgery; 2009 Aug; 146(2):274-81. PubMed ID: 19628085
[TBL] [Abstract][Full Text] [Related]
23. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic and prognostic value of 18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.
Guo H; Zhu H; Xi Y; Zhang B; Li L; Huang Y; Zhang J; Fu Z; Yang G; Yuan S; Yu J
J Nucl Med; 2007 Aug; 48(8):1251-8. PubMed ID: 17631554
[TBL] [Abstract][Full Text] [Related]
25. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT.
Keidar Z; Engel A; Hoffman A; Israel O; Nitecki S
J Nucl Med; 2007 Aug; 48(8):1230-6. PubMed ID: 17631553
[TBL] [Abstract][Full Text] [Related]
26. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
27. Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.
De Giorgi U; Valero V; Rohren E; Dawood S; Ueno NT; Miller MC; Doyle GV; Jackson S; Andreopoulou E; Handy BC; Reuben JM; Fritsche HA; Macapinlac HA; Hortobagyi GN; Cristofanilli M
J Clin Oncol; 2009 Jul; 27(20):3303-11. PubMed ID: 19451443
[TBL] [Abstract][Full Text] [Related]
28. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
[TBL] [Abstract][Full Text] [Related]
29. Monitoring cancer treatment with PET/CT: does it make a difference?
Weber WA; Figlin R
J Nucl Med; 2007 Jan; 48 Suppl 1():36S-44S. PubMed ID: 17204719
[TBL] [Abstract][Full Text] [Related]
30. Integrated PET/CT of salivary gland type carcinoma of the lung in 12 patients.
Jeong SY; Lee KS; Han J; Kim BT; Kim TS; Shim YM; Kim J
AJR Am J Roentgenol; 2007 Dec; 189(6):1407-13. PubMed ID: 18029878
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of neck node status using 18F-FDG PET for salivary duct carcinoma of the major salivary glands.
Kim JY; Lee SW; Kim JS; Kim SY; Nam SY; Choi SH; Roh JL; Choi EK; Kim JH; Song SY; Yoon SM; Kim YS; Kim SS; Park JH; Shin HS; Chang SK; Ahn SD
J Nucl Med; 2012 Jun; 53(6):881-6. PubMed ID: 22573820
[TBL] [Abstract][Full Text] [Related]
32. Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006.
Czernin J; Allen-Auerbach M; Schelbert HR
J Nucl Med; 2007 Jan; 48 Suppl 1():78S-88S. PubMed ID: 17204723
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.
Roh JL; Ryu CH; Choi SH; Kim JS; Lee JH; Cho KJ; Nam SY; Kim SY
J Nucl Med; 2007 Feb; 48(2):240-6. PubMed ID: 17268021
[TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness analysis in the clinical management of patients with known or suspected lung cancer: [18F]fluorodeoxyglucose PET and CT comparison.
Mansueto M; Grimaldi A; Torbica A; Pepe G; Giovacchini G; Messa C; Fazio F
Q J Nucl Med Mol Imaging; 2007 Sep; 51(3):224-34. PubMed ID: 17538525
[TBL] [Abstract][Full Text] [Related]
35. Different intravenous contrast media concentrations do not affect clinical assessment of 18F-fluorodeoxyglucose positron emission tomography/computed tomography scans in an intraindividual comparison.
Prechtel HW; Verburg FA; Palmowski M; Krohn T; Pietsch H; Kuhl CK; Mottaghy FM; Behrendt FF
Invest Radiol; 2012 Sep; 47(9):497-502. PubMed ID: 22820678
[TBL] [Abstract][Full Text] [Related]
36. Demonstrations of AIDS-associated malignancies and infections at FDG PET-CT.
Liu Y
Ann Nucl Med; 2011 Oct; 25(8):536-46. PubMed ID: 21674240
[TBL] [Abstract][Full Text] [Related]
37. The role of ¹⁸F-FDG PET/CT for the diagnosis of infections in patients with hematological malignancies and persistent febrile neutropenia.
Gafter-Gvili A; Paul M; Bernstine H; Vidal L; Ram R; Raanani P; Yeshurun M; Tadmor B; Leibovici L; Shpilberg O; Groshar D
Leuk Res; 2013 Sep; 37(9):1057-62. PubMed ID: 23849986
[TBL] [Abstract][Full Text] [Related]
38. [Detection of pulmonary tumor thrombosis by integrated 18F-FDG PET/CT scans with intravenous contrast].
Valls E; Garcia JR; Rodriguez R; Soler M; Moragas M; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):49-51. PubMed ID: 23177345
[No Abstract] [Full Text] [Related]
39. Malignant tumors of the major salivary glands.
Friedman M; Levin B; Grybauskas V; Strorigl T; Manaligod J; Hill JH; Skolnik E
Otolaryngol Clin North Am; 1986 Nov; 19(4):625-36. PubMed ID: 3797008
[TBL] [Abstract][Full Text] [Related]
40. Positron emission tomography-computed tomography adds to the management of salivary gland malignancies.
Razfar A; Heron DE; Branstetter BF; Seethala RR; Ferris RL
Laryngoscope; 2010 Apr; 120(4):734-8. PubMed ID: 20213798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
